12915583.txt 0 protective efficacy   an aids vaccine   single dna priming followed     single booster     recombinant replicationdefective sendai virus vector     macaque aids model
12915583.txt 1   previously demonstrated   excellent protective efficacy   dna priming followed   gagexpressing sendai virus sev boosting dna primesevgag boost vaccine against   pathogenic simianhuman immunodeficiency virus shiv896pd infection   macaques here   show     established   practical safer aids vaccine protocol   single dna priming followed     single booster     recently developed replicationdefective f deletion sevexpressing gag   show its protective efficacy against shiv896pd infections
12915583.txt 2 
12915583.txt 3 virusspecific cellular immune responses play an important role     control   immunodeficiency virus infections  dna vaccines recombinantviralvectorbased vaccines   their combinations   promising aids vaccine methods because   their potential   inducing cellular immune responses recently some   these aids vaccines inducing virusspecific cellular immune responses have been reported   prevent aids progression   macaque models using pathogenic simianhuman immunodeficiency viruses shiv  members     laboratory previously reported   potential     recombinant sendai virus sev vector   inducing virusspecific cellular immune responses     excellent protective efficacy     vaccine system consisting   dna priming     gagexpressing sev sevgag booster     macaque aids model      preclinical trial dna primingsevgag booster vaccination induced high levels   virusspecific   cells   viremia       vaccinated macaques was controlled     animals were protected   aids progression after   pathogenic shiv shiv896pd challenge sev   an enveloped virus     negativesense rna genome   causes fatal pneumonia   mice its natural host     thought     nonpathogenic   primates including humans    recombinant sev vector system has been shown   induce efficient gene transfer   vitro    recent analysis  confirmed   sev infection   nonpathogenic   macaques     its transmission between them   inefficient intranasal sev inoculation   macaques induces antigen expression localized     nasal mucosa   its primary lymph nodes ln   submandibular ln     retropharyngeal ln furthermore   safer replicationdefective sev vector lacking   f gene fsev has recently become available    dna primesevgag boost regimen reported previously consists     series   four vaccinations   defective proviral dna     single intranasal booster     replicationcompetent sevgag      study   established   practical safer dna primesev boost system   single dna priming followed     single booster     replicationdefective fsevexpressing simian immunodeficiency virus siv gag protein fsevgag   clinical use   an aids vaccine   dna primingboosting regimen called dnafsevgag version 2 used     study consists     single dna vaccination   an intranasal fsevgag booster   week 6 after   priming   dna used     priming referred     cmvshivden was constructed   an env   nef deletion shiv dna sivgp1 dna    replacing   5 long terminal repeat region     cytomegalovirus promoter   an immediateearly enhancer     3 long terminal repeat region   simian virus 40 poly    dna vaccination   animals received 5 mg   cmvshivden dna intramuscularly     booster vaccination   animals received 6 x 109 cellinfectious units   fsevgag intranasally     animal experiments     study were performed   accordance     guidelines   laboratory animals     national institute   infectious diseases   measured virusspecific  cell levels   flowcytometric analysis   gamma interferon ifngamma induction after specific stimulation   described previously    brief lymphocytes were cocultured   autologous herpesvirus papioimmortalized b lymphoblastoid cell lines  infected     recombinant vaccinia virus vector  expressing siv gag   gagspecific stimulation alternatively lymphocytes were cocultured   b lymphoblastoid cell lines infected   vesicular stomatitis virus gpseudotyped sivgp1   shivspecific stimulation gagspecific  cell levels   shivspecific  cell levels were calculated   subtracting ifngammapositive  cell frequencies after nonspecific stimulation   those after gagspecific stimulation   shivspecific stimulation respectively values exceeding 005 were considered positive     first experiment   examined   distribution     fsevgag vector after   booster two cynomolgus macaques macaca fascicularis c97018   c94030 received   dna primefsevgag boost vaccine neither   them showed apparent clinical symptoms both   them were euthanized 2 weeks after   booster   extracted rna     cells prepared   each tissue taken   autopsy   examined fsevgag distribution   detection   siv gag after nested reverse transcriptionpcr amplification   previously described    vector was detected     nasal mucosa   tonsil   submandibular ln     retropharyngeal ln   was undetectable   other lymphoid tissues including peripheral ln  reverse transcriptionpcr   sev nspecific primers showed similar results data   shown these results indicate   fsevgag distribution was restricted     nasal mucosa   its primary lymphoid tissues flowcytometric analysis   gagspecific ifngamma induction   peripheral blood mononuclear cells pbmc     autopsy showed efficient gagspecific  cell induction   both     vaccinated macaques     examined   distribution   gagspecific cd8   cells after   booster while gagspecific cd8   cells were detected       analyzed tissues   nasal mucosa   tonsil   retropharyngeal ln     axillary ln   levels     nasal mucosa     tonsil harboring   vector were higher than those     axillary ln   pbmc      second experiment   evaluated   protective efficacy     dnafsevgag version 2 system     shiv model three rhesus macaques macaca mulatta r00020 r00023   r00024 were vaccinated     challenge experiment none   them showed apparent clinical symptoms after   vaccination   week 6 just before   fsevgag booster shivspecific cd8   cells were undetectable     three animals   significant levels   shivspecific cd4   cells were detected   one animal r00023         others   week 7 1 week after   booster     macaques showed high levels   shivspecific cd4   cd8   cells indicating efficient expansion     number   shivspecific   cells     result     fsevgag booster    levels peaked   around 1 week after   booster macaques r00020   r00023 maintained detectable levels   shivspecific cd8   cells   well   cd4   cells until challenge   week 19 about 3 months after   booster macaque r00024 also maintained shivspecific cd4   cells until challenge   its shivspecific cd8 cell level declined     marginal level before challenge these three macaques were intravenously challenged   10 50 tissue culture infective doses tcid50   shiv896pd  13 weeks after   booster     control experiment performed previously    four naive control macaques showed acute depletion   peripheral cd4   lymphocytes 2 weeks after   challenge after   acute phase   viremia   three     macaques was   controlled     developed aids   were euthanized within   year   contrast   three macaques vaccinated     dnafsevgag version 2 system were protected   acute aids progression  among them two macaques r00020   r00023 were protected   acute cd4 cell depletion their peak viral loads   plasma were greatly reduced geometric mean 59 x 105 copiesml compared   those     controls geometric mean 17 x 107 copiesml   were undetectable     set point acute viremia was   controlled   one macaque r00024   peripheral cd4   cells were lost during   acute phase   viremia was controlled   cd4   cells had recovered     set point     examined shivspecific  cell levels after challenge    macaques r00020   r00023   showed higher levels   protection shivspecific cd8   cells were detectable   pbmc even   week 1 after challenge     vigorous secondary responses were observed after     contrast shivspecific cd8   cells were undetectable   week 1   macaque r00024   showed   lower level   protection although vigorous secondary responses were observed after   these results   compatible   those     previous study indicating   rapid secondary responses   virusspecific cd8   cells   important   controlling acute viremia  levels   shivspecific cd4   cells were augmented       vaccinated macaques   week 15 after challenge  both     macaques     acute viremia was controlled maintained these levels after     macaque r00024 shivspecific cd4   cells became undetectable   week 2     levels recovered after   thus control   shiv infections     dnafsevgag vaccine led   maintenance   virusspecific cd4   cells     set point recently several kinds   dna primeviral vector boost vaccines have been shown   induce protective efficacy against pathogenic shiv infections    those studies dna vaccinations were performed   than once     present study   evaluated   efficacy     dna primesev boost system   minimum numbers   vaccinations   an shiv model furthermore   study     first preclinical trial     replicationdefective fsev vector     vaccine tool   macaques   vector distribution was localized     nasal mucosa its primary ln     tonsil after an intranasal fsevgag booster   distribution was similar       replicationcompetent sevgag gagspecific cd8   cells were detected predominantly     nasal mucosa     tonsil suggesting     vectorderived antigen presentation was predominant   these tissues   addition     local induction   intranasal fsevgag injection induced gagspecific cd8   cells     produced systemically these results indicate     fsev vector     promising vaccine tool   inducing virusspecific cellular immune responses     previous study  members     laboratory showed     production   shivspecific   cells was efficiently induced     four macaques vaccinated     dnasevgag version 1 system consisting     series   four dna vaccinations     replicationcompetent sevgag booster     them maintained shivspecific cd8   cells     than 3 months until challenge   acute viremia was controlled without acute cd4 cell depletion after shiv896pd challenge two   three macaques vaccinated     dnafsevgag version 2 system     study showed similar levels   protection acute viremia was controlled without acute cd4 cell depletion     were protected   aids progression     other hand     remaining macaque r00024     marginal level   shivspecific cd8   cells   challenge acute viremia was uncontrolled     was acute cd4 cell depletion however even   macaque r00024 shiv896pd infections were controlled     set point cd4   cells recovered     animal was protected   aids progression while two levels   protection were observed   study indicates   even   dnafsevgag version 2 aids vaccine system     minimum number   vaccinations can induce protective immune responses     macaque aids model
12915583.txt 4 gagspecific cd8 cell levels   tissues after an intranasal fsevgag booster gagspecific cd8 cell levels   tissues after an intranasal fsevgag booster samples were obtained   two cynomolgus macaques c97018   c94030   were euthanized 2 weeks after an intranasal fsevgag booster numbers   gagspecific cd8   cells   shown   percentages     total number   cd8   cells   shown   percentages     total number   cd81   cells   lower panels show representative dot plots   ifng induction   cd81   cells after gagspecific stimulation dot plots gated   cd31 cd81 lymphocytes     tonsil left     retropharyngeal ln right   macaque c97018   shown ax ln axillary ln rp ln retropharyngeal ln
12915583.txt 5 shivspecific cell levels   pbmc before     after b challenge shivspecific cell levels   pbmc before     after b challenge   three vaccinated rhesus macaques numbers   shivspecific cd4   cells left panels   numbers   shivspecific cd8   cells right panels   shown   percentages     total numbers   cd4   cd8   cells respectively     levels   week 6 just before   fsevgag booster week 7 1 week after   booster week 8 2 weeks after   booster   week 19 just before shiv challenge after   initial dna priming   shown b   levels   weeks 1 15 2   20 after challenge   shown
12915583.txt 6 changes   peripheral cd4 cell counts   plasma viral loads after shiv89 changes   peripheral cd4 cell counts   plasma viral loads after shiv896pd challenge   left panels show results   previously described naive control macaques 17     right panels show results   macaques vaccinated     dna primefsevgag boost vaccine   changes   relative peripheral cd4 cell counts per microliter   each animal   cd4 count     challenge   considered     100     values     cd4 counts relative         challenge   shown b changes   plasma shiv rna copy numbers numbers   copies per milliliter quantified   described previously 
12915583.txt 7 distribution   siv gag rna 2 weeks after   fsevgag booster
12915583.txt 8 
